Product Code: ML00026-033
Since the World Health Organization (WHO) declared COVID-19 to be a pandemic in March, the toll of lockdown measures across the world has been severe in most sectors. However, there are sectors which have seen demand for at least some of their goods and services increase during this otherwise disastrous period
Racing to produce diagnostic tools, therapies and treatments for COVID-19, pharmaceutical and medical device companies are working both independently and in partnership with the public sector to meet demand. New entrants from other sectors are further intensifying competition, and tech giants are accelerating their long-term healthcare strategies.
Supermarkets around the world have become focal points of demand as the hospitality sector effectively shuts down. Restaurants and cafes which have managed to continue operating have done so through delivery services, which are busier than ever.
The confluence of these two areas of demand is grocery delivery, a global trend which has been accelerated.
Remote working has become essential for businesses under lockdown, and for many the shift has exposed a huge gap in their IT infrastructure. Providers of Unified Communication and Collaboration (UC&C) services have stepped in to facilitate remote working at scale, and a raft of marketing campaigns has taken off as the market rapidly diversifies.
- See how the global pandemic has changed the world economy
- Examine which industries have fared well during this time
- See what are key players doing to survive and thrive
- Long term, learn what the implications for these industries is
- Reasons to Buy
- Who are the major players that will do well from the change in global economic dynamics?
- How can players change their strategies to improve their responses?
- What industries are naturally setup to do well from the changes COVID-19 has inflicted?
- Just how long term are these global economic issues going to be?
Table of Contents
1.Pharma and Medical Devices
- 1.1.Big pharmas are competing to beat the virus
- 1.1.1.Work with the public sector massively outweighs that with the private
- 1.1.2.Gilead's remdesivir is currently the biggest contender
- 1.1.3.Demand is needed to compensate for the risks to the industry
- 1.2.The US is leading a boom in medical device R&D
- 1.2.1.US leads global output, with companies competing independently and in partnerships
- 1.2.2.Greatest demand comes from in vitro diagnostics
- 1.2.3.External competitors are weighing in
- 1.3.Tech companies are bringing new healthcare solutions to market
- 1.3.1.Amazon's healthcare ascendance has been accelerated
- 1.3.2.Tech giants are weighing in with tracking apps
2.Food Retail and Delivery
- 2.1.The door has closed on hospitality as another opens for food retail
- 2.1.1.Patterns of demand for groceries have changed
- 2.2.Sharing economy apps gain from both food retail and hospitality
- 2.2.1.Lockdown could hasten trends towards grocery delivery
- 2.2.2.COVID-19's impact on diverse global delivery apps will be ubiquitous
- 3.1.IT providers will see lasting gains from a change in business practices
- 3.1.1.Remote working boom comes at a time of transition
- 3.2.1.UC&C providers have a crucial marketing opportunity
- 3.2.Diversification of the market is ramping up
- 3.2.1.The UC&C market will continue to diversify with disruptive new entrants
- 3.2.2.Cloud services have also become vital
4.Consumer Tech Services
- 4.1.Social media and streaming are benefitting from captive audiences
- 4.1.1.Streamers' preparedness for long-term impacts will vary
- 4.1.2.Keeping users locked in will differentiate more established players
- 4.1.3.Social media also needs to retain new users after lockdown
5.Private Equity funds
- 5.1.Private Equity funds are eyeing up struggling public companies
- 5.1.1.PIPE deals are already on the rise
- 5.1.1.Private equity funds have huge stores of cash to invest
- 5.1.3.Strong but struggling public companies present an opportunity